Skip to main content
. 2019 Apr 3;5(5):796–807. doi: 10.1021/acscentsci.9b00060

Scheme 1. Schematic Illustration of A/M/C-MNC for Immunotherapy.

Scheme 1

(A) Fabrication process of A/M/C-MNC. (B) Illustration of A/M/C-MNC-mediated cellular immune responses eliciting cytotoxicity T lymphocytes (CTLs) and memory T cells (TM cells) for cancer immunotherapy.